THIRD TIME'S A CHARM: TREATING PULMONARY EMBOLISM WITH MECHANICAL THROMBECTOMY AFTER TWO FAILED ATTEMPTS WITH THROMBOLYTIC THERAPY

نویسندگان

چکیده

TOPIC: Procedures TYPE: Medical Student/Resident Case Reports INTRODUCTION: Pulmonary embolism (PE) can be a life-threatening condition. Massive PE, characterized by hemodynamic instability with signs of shock, comprises 4.5%-10% all PE cases and has over 50% mortality rate. When medical therapy fails, aspiration thrombectomy is treatment option for acute massive or submassive in patients compromise right ventricular (RV) dysfunction (Dopazo et al, 2018). CASE PRESENTATION: A 61-year-old male presented after an episode syncope, chest pain, dyspnea. Due to profound hypoxia, he was intubated. ECG as seen figure 1 changed from prior. Troponin 0.80. In the ED, placed on norepinephrine epinephrine due hypotension. Bedside echocardiogram (ECHO) showed enlarged RV severely reduced systolic function, hypokinetic free wall, apex. The patient subsequently developed pulseless electrical activity (PEA) arrest. Two cycles CPR were performed achieve return spontaneous circulation. possibility weight-based tPA administered. He had PEA arrest second time done 9 minutes. dose given which his hemodynamics transiently improved. Epinephrine drip discontinued, but continued. transferred ICU monitoring heparin drip. Over next 12 hours, despite multiple doses, progressively decompensated blood pressure 40mmHg while norepinephrine. Vasopressin initiated. Lactic acidosis increased 3.8 6.6 mmol/L, creatinine worsened 1.6 4.0 mg/dL, Hb 12.2 8.5 g/dL. CTA confirmed saddle pulmonary evidence strain RV/LV ratio 1.1. taken emergently cardiac catheterization vasopressors. bilateral artery T24 Inari catheter successfully, subsequent improvement hemodynamics. ECHO procedure improved function size reduction. Within 24 hours thrombectomy, vasopressors titrated off remained hemodynamically stable. DISCUSSION: Though systemic thrombolytic typically indicated unstable suspected emboli, it not effective our patient, doses. Catheter-directed therapies remove obstructive emboli directly, allowing rapid case. Furthermore, though invasive strategy, catheter-directed potential offer both short- long-term benefits thrombolysis including early recovery, risk bleeding, hypertension, reversal failure. CONCLUSIONS: techniques should considered case-by-case basis, especially who do improve thrombolysis. REFERENCE #1: 1.Ciampi-Dopazo, Juan José al. "Aspiration Thrombectomy Treatment Acute Submassive Embolism: Initial Single-Center Prospective Experience.” Journal vascular interventional radiology : JVIR vol. 29,1 (2018): 101-106. doi:10.1016/j.jvir.2017.08.010 #2: 2.Tu, Thomas "A Prospective, Single-Arm, Multicenter Trial Catheter-Directed Mechanical Intermediate-Risk FLARE Study.” JACC. Cardiovascular interventions 12,9 (2019): 859-869. doi:10.1016/j.jcin.2018.12.022 DISCLOSURES: No relevant relationships Mukul Bhattarai, source=Web Response radhika deshpande, no disclosure file Abdul Hafiz; Cameron Koester, Abhishek Kalidas Kulkarni, Mohsin Salih; Omar Siddiqui,

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Stroke and cardiac papillary fibroelastoma: mechanical thrombectomy after thrombolytic therapy.

We describe a case of a 34-year-old man with a sudden development of right hemiparesis and aphasia because of infarction of the left middle cerebral artery that was submitted to intravenous (IV) recombinant tissue plasminogen activator and mechanical thrombectomy. Transesophageal echocardiogram showed a small mass on the anterior leaflet of the mitral valve. Cardiac surgery was performed, and h...

متن کامل

Pulmonary Embolism Thrombolytic Therapy of Pulmonary Embolism A Meta-Analysis

OBJECTIVES We sought to assess the efficacy and safety of thrombolytic therapy in patients with an acute pulmonary embolism (PE). BACKGROUND Thrombolytic therapy is approved for the treatment of acute PE; however, the safety and efficacy of this therapy remain debated. METHODS A meta-analysis of randomized, controlled trials comparing thrombolytic agents with intravenous heparin in patients wit...

متن کامل

[Thrombolytic therapy of acute pulmonary embolism].

Thrombolytic therapy accelerates the dissolution of acute pulmonary embolism and is potentially lifesaving. The goal of this article is to offer a critical analysis of the use of thrombolytic therapy in this setting. Guidelines have been written and modified and new ones have been published over the past several years. Although an evidence base exists, unanswered questions remain. Despite the p...

متن کامل

Thrombolytic treatment of pulmonary embolism with APSAC.

BRL 26921 (Eminase registered trade mark in Belgium, Germany and The Netherlands) is the p-anisoyl derivative of the primary (human) lys plasminogen-streptokinase activator complex (APSAC). The acyl-enzyme has the theoretical advantage of causing fibrinolysis in situ in the presence of fibrin clotbound plasminogen. It was administered to 34 patients with severe pulmonary embolism (PE) in an ope...

متن کامل

Thrombolytic therapy in a patient with suspected pulmonary embolism despite a negative computed tomography pulmonary angiogram.

We report a case of a 62-year-old male who presented to our intensive care unit with hypoxemia 6 hours after retinal surgery. He had a negative computed tomography (CT) pulmonary angiogram, but an emergency echocardiogram revealed the McConnell sign. He was thrombolysed and had rapid improvement in oxygenation and hemodynamics. Thrombolysis in hemodynamically unstable pulmonary embolism is not ...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Chest

سال: 2021

ISSN: ['0012-3692', '1931-3543']

DOI: https://doi.org/10.1016/j.chest.2021.07.1771